Electrochemical RT activity assay for measuring HIV load
DESCRIPTION (provided by applicant): In this Phase I SBIR project Alderon Biosciences Inc. (ABI) proposes to demonstrate the feasibility of using electrochemical reverse transcriptase (eRT) assays for determinations of HIV viral load in clinical samples. Success will set the stage for Phase II development, FDA approval, and production of commercial kits using this advanced technology. The long-range goal is to produce an affordable (equal to or
Small Business Information at Submission:
Alderon Biosciences, Inc.
Alderon Biosciences, Inc. 2810 Meridian Pky, Ste 152 Durham, NC 27713
Number of Employees: